Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives Average Recommendation of “Moderate Buy” from Analysts

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) has earned an average rating of “Moderate Buy” from the nine research firms that are currently covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $10.78.

Several equities analysts have commented on the company. The Goldman Sachs Group increased their target price on Maravai LifeSciences from $7.00 to $8.00 and gave the company a “neutral” rating in a research report on Thursday, August 8th. Wells Fargo & Company started coverage on Maravai LifeSciences in a research report on Tuesday, August 27th. They set an “overweight” rating and a $10.00 price objective for the company. UBS Group raised their price objective on Maravai LifeSciences from $8.50 to $11.00 and gave the stock a “neutral” rating in a research report on Thursday, August 8th. Morgan Stanley downgraded Maravai LifeSciences from an “overweight” rating to an “equal weight” rating and lowered their price objective for the stock from $11.00 to $10.00 in a research report on Tuesday, August 13th. Finally, Royal Bank of Canada restated an “outperform” rating and set a $15.00 price objective on shares of Maravai LifeSciences in a research report on Friday, August 16th.

Institutional Investors Weigh In On Maravai LifeSciences

Several large investors have recently added to or reduced their stakes in MRVI. GAMMA Investing LLC grew its stake in Maravai LifeSciences by 310.2% during the second quarter. GAMMA Investing LLC now owns 3,585 shares of the company’s stock worth $26,000 after purchasing an additional 2,711 shares during the period. Point72 Asia Singapore Pte. Ltd. acquired a new stake in Maravai LifeSciences in the second quarter valued at approximately $32,000. Headlands Technologies LLC acquired a new stake in Maravai LifeSciences in the first quarter valued at approximately $42,000. Blue Trust Inc. acquired a new stake in Maravai LifeSciences in the second quarter valued at approximately $44,000. Finally, Delap Wealth Advisory LLC acquired a new stake in Maravai LifeSciences in the first quarter valued at approximately $106,000. Institutional investors and hedge funds own 50.25% of the company’s stock.

Maravai LifeSciences Price Performance

Maravai LifeSciences stock opened at $7.83 on Thursday. The company has a current ratio of 10.00, a quick ratio of 9.28 and a debt-to-equity ratio of 0.71. The company has a market capitalization of $1.97 billion, a PE ratio of -7.99 and a beta of 0.01. Maravai LifeSciences has a 12 month low of $4.52 and a 12 month high of $11.56. The stock has a 50-day moving average price of $8.77 and a two-hundred day moving average price of $8.61.

Maravai LifeSciences (NASDAQ:MRVI) last posted its earnings results on Wednesday, August 7th. The company reported ($0.08) EPS for the quarter. The firm had revenue of $73.40 million during the quarter, compared to the consensus estimate of $71.64 million. Maravai LifeSciences had a negative net margin of 47.41% and a negative return on equity of 4.78%. Maravai LifeSciences’s revenue for the quarter was up 6.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted ($0.06) earnings per share. Analysts expect that Maravai LifeSciences will post -0.17 EPS for the current year.

About Maravai LifeSciences

Maravai LifeSciences Holdings, Inc, a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company’s products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species.